You are here: Industry Insights > heart attack

News List

Calcium PET/CT testing in coronary arteries predicts heart attack risk europeanpharmaceuticalreview
March 14, 2018
Researchers have found that incorporating imaging technologies more precisely can predict heart attack risk…
Improved heart attack test could save millions for NHS pharmafile
September 28, 2017
A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test that could potentially save millions across the NHS.
One in ten men have ‘older’ hearts than they are pharmatimes
September 05, 2017
A Public Health England analysis shows that one in 10 men have a heart age 10 years older than they are, with 64 percent of them being male, rising their risk for heart attack or stroke.
Merck still mulling over filing CETP med as it posts 'lackluster' data fiercepharma
August 30, 2017
Anacetrapib is designed to ward off heart attacks and strokes by blocking the protein CETP and thus boosting “good,” cholesterol
Some heart attack patients may not benefit from beta blockers worldpharmanews
June 01, 2017
New research challenges established medical practice that all heart attack patients should be on beta blockers. The study - by a research team at the University of Leeds - looked at patients who had a heart attack but did not suffer heart failure...
Heart Attack Risk Spikes After Respiratory Infection, Study Finds drugs.com
May 17, 2017
The risk of heart attack increases sharply after a respiratory infection, a new study finds.
Too Many People Still Ignore Heart Attack Risks: Study drugs.com
May 04, 2017
Sizable numbers of adults with risk factors for heart attack -- such as smoking, obesity or physical inactivity -- aren't inclined to do anything to improve their health, a large, new study finds.
Fish Oil Pills May Help After Heart Attack, Specialists Say drugs.com
March 14, 2017
Doctors may want to consider prescribing fish oil pills to heart attack survivors and patients with chronic heart failure, new recommendations from the American Heart Association suggest.
TiGenix announces success of novel heart attack stem cell trial pharmafile
March 14, 2017
Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem cells (AlloCSCs) in the treatment of acute myocardial infarction (AMI)

Previous page 1 2 3 Next page